YTHDF2 and acute myeloid leukemia: By binding to Tumor Necrosis Factor Receptor 2 (TNFR2), YTHDF2 accelerates the degradation of TNFR2 mRNAs, thus inhibiting the TNF signaling pathway and participating in AML progression [105].